Treat-to-target Endpoint Definitions in Systemic Lupus Erythematosus: More Is Less?

被引：6
|
作者：
Morand, Eric F. [1 ,2 ]
Golder, Vera [3 ]
机构：
[1] Monash Univ, Sch Clin Sci, Clayton, Vic, Australia
[2] Monash Hlth, Rheumatol, Melbourne, Vic, Australia
[3] Monash Hlth, Melbourne, Vic, Australia
来源：
JOURNAL OF RHEUMATOLOGY | 2019年 / 46卷 / 10期
关键词：
DISEASE-ACTIVITY STATE; RHEUMATOID-ARTHRITIS; REMISSION; RECOMMENDATIONS; SLE;
D O I：
10.3899/jrheum.190223
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1256 / 1258
页数：3
相关论文
共 50 条
  • [21] Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force
    Piga, Matteo
    Parodis, Ioannis
    Touma, Zahi
    Legge, Alexandra
    Ugarte-Gil, Manuel F.
    Hmamouchi, Ihsane
    Puerta, Jose A. Gomez
    Devilliers, Herve
    Zen, Margherita
    Cho, Jiacai
    Ziade, Nelly
    Mucke, Johanna
    Toro-Gutierrez, Carlos Enrique
    Izuka, Shinji
    Korsten, Peter
    Kane, Baidy S. Y.
    Golder, Vera
    Chong, Benjamin F.
    Pons-Estel, Guillermo
    Chasset, Francois
    Arnaud, Laurent
    AUTOIMMUNITY REVIEWS, 2025, 24 (05)
  • [22] Egyptian recommendations for the management of systemic lupus erythematosus: a consensus, evidence-based, clinical practice guidelines for treat-to-target management
    Yasser El Miedany
    Khaled Elhadidi
    Geilan Abdelmoneim Mahmoud
    Mohammed Hassan Abu-Zaid
    Atef Abdelazim Mahmoud
    Maha El Gaafary
    Nadia Kamel
    Nihal Ahmed Fathi
    Ahmed Abdel Nasser
    Waleed Hassan
    Mervat Eissa
    Eman Sarhan
    Essam Aboalfadl
    Ahmed Ezzat Mansour
    Mohamed Mortada
    Nermeen Ahmed Fouad
    Ismail Elaraby
    Rehab Elnemr
    Basma M. Medhat
    Sally S. Mohamed
    Rehab Ali Ibrahim
    Samar abd Alhamed Tabra
    Sally Saber
    Genny Franklin
    Abir Mokbel
    Egyptian Rheumatology and Rehabilitation, 50
  • [23] Is Treat-to-target in Lupus Nephritis Realistic in Clinical Practice?
    Mok, Chi Chiu
    CURRENT RHEUMATOLOGY REVIEWS, 2019, 15 (01) : 2 - 6
  • [24] Treat-to-target and shared decision-making in systemic lupus erythematosus from the patients' perspective: results from an international patient survey
    Mucke, J.
    Pencheva, D. T.
    Sanchez, A. R. Parra
    Cramer, K.
    Schneider, M.
    Bultink, I. E. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 1744 - 1749
  • [25] Treat-to-target in Crohn's disease:Will transmural healing become a therapeutic endpoint?
    Elena Daniela Serban
    World Journal of Clinical Cases, 2018, 6 (12) : 501 - 513
  • [26] Uricaemia as a surrogate endpoint in gout trials and the treat-to-target approach for gout management
    Bardin, Thomas
    Richette, Pascal
    LANCET RHEUMATOLOGY, 2022, 4 (01): : E7 - E8
  • [27] Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus
    Gustafsson, Johanna T.
    Svenungsson, Elisabet
    AUTOIMMUNITY, 2014, 47 (02) : 67 - 76
  • [28] Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas
    Rekvig, Ole Petter
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [29] Treat-to-target in Crohn's disease: Will transmural healing become a therapeutic endpoint?
    Serban, Elena Daniela
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (12) : 501 - 513
  • [30] To target or not to target APRIL in systemic lupus erythematosus: that is the question!
    Morel, Jacques
    Hahne, Michael
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (01)
12345